MAP PHARMACEUTICALS, INC. Operating Margin
- Operating margin · 12 months: Value -1589.64%; Formula and calculation Operating income / revenue. Period ending 2012-09-30..
Operating margin
Overview →Financial period ending 2012-09-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Operating margin · 12 months | -1589.64% | Operating income / revenue. Period ending 2012-09-30. $-57.56M ÷ $3.62M × 100 ≈ -1589.64% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating income | -57.56M USD | Operating Income (Loss) |
| Revenue | 3.62M USD | |
| Cost of products and services | (m) | |
| Research and development | 34.70M USD | Research and Development Expense |
| Selling, general and administration | 26.48M USD | Selling, General and Administrative Expense |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Operating income (USD) | Revenue (USD) | Cost of products and services (USD) | Research and development (USD) | Selling, general and administration (USD) | Operating margin |
|---|---|---|---|---|---|---|
| 2012-09-30 | $-57.56M | $3.62M | (m) | $34.70M | $26.48M | -1589.64% |
| 2012-06-30 | $-36.72M | $23.58M | (m) | $33.57M | $26.73M | -155.73% |
| 2012-03-31 | $-34.64M | $23.54M | (m) | $33.06M | $25.13M | -147.18% |
| 2011-12-31 | $-32.65M | $23.07M | (m) | $33.66M | $22.06M | -141.55% |
| 2011-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-12-31 | $-53.49M | (m) | (m) | $37.77M | $15.71M | (m) |
| 2010-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2009-12-31 | $-6.97M | $54.17M | (m) | $48.00M | $13.14M | -12.87% |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.